Bolstering current therapeutic antibody treatments to help fight Omicron infections

By | January 10, 2022
Researchers test the neutralizing action of a panel of eight therapeutic monoclonal antibodies against the SARS-CoV-2 Omicron (B.1.1.529) variant.